Review in the Recent Advances in Host Immune Molecules and Autoimmune Diseases

Open Access

Issue		BIO Web Conf. Volume 237, 2026 2026 8^th International Conference on Biotechnology and Biomedicine (ICBB 2026)


Article Number		01016
Number of page(s)		6
Section		Molecular and Cellular Pathophysiology
DOI		https://doi.org/10.1051/bioconf/202623701016
Published online		10 June 2026

Aristizábal B, González Á. Innate immune system. In: Autoimmunity: From Bench to Bedside [Internet]. El Rosario University Press; 2013. [Google Scholar]
Arneth B. Molecular Mechanisms of Immune Regulation: A Review. Cells. 2025;14(4):283. [Google Scholar]
Karki R, Kanneganti TD. The ‘Cytokine Storm’: molecular mechanisms and therapeutic prospects. Trends Immunol. 2021;42(8):681–705. [Google Scholar]
Ding Q, Hu W, Wang R, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8(1):68. [Google Scholar]
Ghorbaninezhad F, Leone P, Alemohammad H, et al. Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review). Int J Mol Med. 2022;49(4):1–13. [Google Scholar]
Ohara D, Takeuchi Y, Hirota K. Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells. Cell Mol Immunol. 2024;21(11):1183–1200. [Google Scholar]
Gonzalez Caldito N. Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders. Front Immunol. 2023;14:1213448. [Google Scholar]
Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10(1):102. [Google Scholar]
Ji L, Li T, Chen H, et al. The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 2023;13(1):230. [Google Scholar]
Joshi S, Kaur S, Redig AJ, et al. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci. 2009;106(29):12097–12102. [Google Scholar]
Shrivastav M, Niewold TB. Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus. Front Immunol. 2013;4:319. [Google Scholar]
Hagiwara AM, Moore RE, Wallace DJ, Ishimori M, Jefferies CA. Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus. Rheumatol Immunol Res. 2021;2(3):173–184. [Google Scholar]
Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol. 2020;67:87–94. [Google Scholar]
Huangfu L, Li R, Huang Y, Wang S. The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8(1):402. [Google Scholar]
Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res Ther. 2001;3(3):168. [Google Scholar]
Menter A, Krueger GG, Paek SY, Kivelevitch D, Adamopoulos IE, Langley RG. Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities. Dermatol Ther. 2021;11(2):385–400. [Google Scholar]
Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013;5:79–99. [Google Scholar]
Richter P, Macovei LA, Rezus C, Boiculese VL, Buliga-Finis ON, Rezus E. IL-10 in Systemic Lupus Erythematosus: Balancing Immunoregulation and Autoimmunity. Int J Mol Sci. 2025;26(7):3290. [Google Scholar]
Gomes-Santos AC, Moreira TG, Castro-Junior AB, et al. New Insights into the Immunological Changes in IL-10-Deficient Mice during the Course of Spontaneous Inflammation in the Gut Mucosa. Clin Dev Immunol. 2012;2012:560817. [Google Scholar]
Rodari MM, Cerf-Bensussan N, Parlato M. Dysregulation of the immune response in TGF-β signalopathies. Front Immunol. 2022;13. [Google Scholar]
Pan Z, Zhu T, Liu Y, Zhang N. Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases. Front Immunol. 2022;13. [Google Scholar]
Stem-like and effector peripheral helper T cells comprise distinct subsets in rheumatoid arthritis | Science Immunology. [Google Scholar]
Duarte-Delgado NP, Segura K, Gómez O, et al. Cytokine profiles and their correlation with clinical and blood parameters in rheumatoid arthritis and systemic lupus erythematosus. Sci Rep. 2024;14(1):23475. [Google Scholar]
Donniacuo A, Mauro A, Cardamone C, et al. Comprehensive Profiling of Cytokines and Growth Factors: Pathogenic Roles and Clinical Applications in Autoimmune Diseases. Int J Mol Sci. 2025;26(18):8921. [Google Scholar]
Bonelli M, Kerschbaumer A, Kastrati K, et al. Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Ann Rheum Dis. 2024;83(2):139–160. [Google Scholar]
Gargiulo L, Ibba L, Malagoli P, et al. Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis). Front Immunol. 2023;14:1341708. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.